OSU K12 Training Grant in Oncology
OSU K12 肿瘤学培训补助金
基本信息
- 批准号:10477991
- 负责人:
- 金额:$ 81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-09 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Applied ResearchAreaBasic ScienceClinicalClinical InvestigatorClinical ResearchClinical TrialsComprehensive Cancer CenterDisciplineDoctor of PhilosophyEnsureFacultyFinancial SupportGoalsGrantHematologyIndividualInvestigationInvestigational TherapiesLaboratoriesMalignant NeoplasmsMedical OncologyMedicineMentored Clinical Scientist Development ProgramMentorsMinority GroupsOhioOncologyPaperPeer ReviewProgram EvaluationRadiation OncologyResearchResearch PersonnelResourcesSECTM1 geneStructureSurgical OncologyTrainingTraining ProgramsUnderserved PopulationUniversitiesWomen&aposs Groupanticancer researchbasecancer diagnosiscancer preventioncareercareer developmentdrug developmenteducation researcheffectiveness evaluationinterestlaboratory developmentprogramsrecruitsuccesssurvivorshiptranslational cancer researchtranslational scientist
项目摘要
Project Summary/Abstract
The goal of this proposal is to mentor and train junior faculty investigators in laboratory and/or clinical translational
cancer research. Implementation of this K12 program for the career development of laboratory-based
(PhD/DVM/MD) and clinical (MD or MD/PhD) translational scientists in diverse areas of oncology will ensure a
cadre of highly-trained individuals who can communicate across disciplines to drive new advancements in how
we approach cancer diagnosis and management. This K12 program from The Ohio State University
Comprehensive Cancer Center (OSUCCC) continues its focus on early drug development, but now also extends
to cancer prevention, control and survivorship research. The OSUCCC is clearly dedicated to research education
and providing outstanding career development and mentoring opportunities to promising junior faculty. The
Divisions of Hematology, Medical Oncology, Radiation Oncology, and Surgical Oncology each have robust
programs that are continuously recruiting new junior faculty to facilitate expansion of our cancer program.
Recruitment efforts also emphasize the inclusion of women, minorities and underserved groups to increase
diversity. This K12 grant fills an important need by extending research education, career development and
mentoring to junior faculty interested in establishing academic research careers. It is the only OSUCCC training
program dedicated solely to faculty-level career development in cancer research, and thus has no overlap with
any of the OSU T32 training grants, which focus on fellows. This strategy ensures continuity in training and
provides individuals a structured path to become independent clinical or translational investigators. The quality
of this K12 program and its success in training cancer researchers is exemplified by the career trajectories of
past trainees, their papers, grants, clinical trials and other scholarly activities that have driven new discoveries.
The continued success of this program will be ensured by the overall strength and direction of the OSUCCC, as
demonstrated by its recent peer review score of 10 (exceptional), financial support of this K12 program by the
OSUCCC and by different Divisions and Departments, and the enormous breadth of expertise and resources
available at OSU. This K12 program seeks to train two types of investigators. The first includes MD and/or PhD
faculty who have outstanding basic science training and want to pursue laboratory-based investigation related
to applied research in experimental therapeutics, cancer prevention, control, and survivorship. The second group
includes MD or MD/PhD faculty who want to pursue clinical research in experimental therapeutics and cancer
prevention, control, or survivorship. Training plans are tailored to each individual trainee to facilitate their
success, with inclusion of a robust evaluation program to assess the effectiveness of the K12. The value of the
OSU K12 program is best demonstrated by nearly all of the current and past K12 scholars remaining in academic
medicine and moving forward as independent laboratory or clinical investigators.
项目总结/摘要
本提案的目标是指导和培训实验室和/或临床转化领域的初级教师研究人员
癌症研究。该K12计划的实施,为实验室为基础的职业发展
(PhD/DVM/MD)和临床(MD或MD/PhD)肿瘤学不同领域的转化科学家将确保
一批训练有素的人员,他们可以跨学科进行沟通,推动在以下方面取得新的进展:
我们致力于癌症的诊断和治疗。俄亥俄州州立大学的K12项目
综合癌症中心(OSUCCC)继续专注于早期药物开发,但现在也扩展了
癌症预防、控制和生存研究。OSUCCC显然致力于研究教育
并为有前途的初级教师提供出色的职业发展和指导机会。的
血液学、内科肿瘤学、放射肿瘤学和外科肿瘤学各部门都有强大的
这些项目正在不断招募新的初级教师,以促进我们癌症项目的扩展。
征聘工作还强调吸收妇女、少数民族和得不到充分服务的群体,
多样性这K12赠款填补了扩大研究教育,职业发展和
指导有兴趣建立学术研究事业的初级教师。OSUCCC培训
该计划专门致力于癌症研究的教师级职业发展,因此与
任何俄勒冈州立大学T32培训赠款,重点是研究员。这一战略确保了培训的连续性,
为个人提供了一个结构化的途径,成为独立的临床或翻译研究者。质量
这个K12计划及其在培训癌症研究人员方面的成功体现在以下职业轨迹中:
过去的学员,他们的论文,赠款,临床试验和其他学术活动,推动了新的发现。
OSUCCC的整体实力和方向将确保该计划的持续成功,
通过其最近的同行评审评分10(特殊),该K12计划的财政支持,
OSUCCC和不同的司和部门,以及专业知识和资源的巨大广度
在OSU可用。K12计划旨在培训两种类型的调查人员。第一个包括MD和/或PhD
教师谁拥有优秀的基础科学培训,并希望追求实验室为基础的调查相关
实验疗法、癌症预防、控制和生存的应用研究。第二组
包括医学博士或医学博士/博士教师谁想要追求在实验治疗和癌症的临床研究
预防、控制或生存。培训计划是为每个学员量身定制的,以促进他们的
成功,包括一个强大的评估计划,以评估K12的有效性。的值
俄勒冈州立大学K12计划是最好的证明,几乎所有的当前和过去的K12学者留在学术
作为独立的实验室或临床研究者向前迈进。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM E. CARSON其他文献
WILLIAM E. CARSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM E. CARSON', 18)}}的其他基金
Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
用于三阴性乳腺癌化学免疫治疗的双有效负载抗体-药物偶联物
- 批准号:
10711488 - 财政年份:2023
- 资助金额:
$ 81万 - 项目类别:
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
优化 RNA 纳米粒子的大小和形状以增强癌症靶向和治疗
- 批准号:
9166825 - 财政年份:2016
- 资助金额:
$ 81万 - 项目类别:
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
优化 RNA 纳米粒子的大小和形状以增强癌症靶向和治疗
- 批准号:
9763480 - 财政年份:2016
- 资助金额:
$ 81万 - 项目类别:
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
优化 RNA 纳米粒子的大小和形状以增强癌症靶向和治疗
- 批准号:
10006088 - 财政年份:2016
- 资助金额:
$ 81万 - 项目类别:
Cetuximab Therapy of Pancreatic Cancer: Immune Modulation with IL-21
西妥昔单抗治疗胰腺癌:IL-21 的免疫调节
- 批准号:
7740058 - 财政年份:2009
- 资助金额:
$ 81万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
7313944 - 财政年份:2007
- 资助金额:
$ 81万 - 项目类别:
Therapy of Melanoma with Bortezomib and Interferon-alpha
硼替佐米和干扰素-α 治疗黑色素瘤
- 批准号:
7418854 - 财政年份:2006
- 资助金额:
$ 81万 - 项目类别:
Therapy of Melanoma with Bortezomib and Interferon-alpha
硼替佐米和干扰素-α 治疗黑色素瘤
- 批准号:
7056407 - 财政年份:2006
- 资助金额:
$ 81万 - 项目类别:
Therapy of Melanoma with Bortezomib and Interferon-alpha
硼替佐米和干扰素-α 治疗黑色素瘤
- 批准号:
7230025 - 财政年份:2006
- 资助金额:
$ 81万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Research Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Major Research Instrumentation
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 81万 - 项目类别:
Standard Grant